TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GH

Guardant Health Inc

Healthcare · Diagnostics & Research

177.20$ +1.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GH
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
87.6% 63.4% 47.7% 33.0% 32.3% 32.9% 34.8% 40.3% 39.2% 35.5%
12.4% 36.6% 52.3% 67.0% 67.7% 67.1% 65.2% 59.7% 60.8% 64.5%
43.0% 51.3% 56.0% 40.3% 52.3% 70.4% 83.2% 65.1% 47.1% 37.1%
39.3% 73.8% 39.9% 28.6% 67.2% 55.3% 36.5% 27.6% 24.4% 21.5%
186.0% 190.3% 154.9% 105.4% 156.6% 177.1% 186.3% 159.9% 120.8% 109.0%
-173.7% -153.7% -102.5% -38.4% -88.9% -110.0% -121.1% -100.1% -60.0% -44.5%
12.0% 5.4% 1.4% 0.6% 1.7% 0.7% 0.6% 0.5% 0.3% 0.4%
-182.7% -167.0% -92.9% -32.5% -85.8% -102.9% -145.4% -84.9% -58.9% -42.5%
0.0% 0.0% 0.0% -0.9% 0.1% 0.1% 0.3% 0.1% 0.2% -0.1%
-182.7% -167.0% -93.8% -35.3% -88.5% -108.6% -145.6% -85.0% -59.0% -42.4%
-156.1% -151.1% -83.7% -25.6% -78.5% -96.2% -136.8% -76.8% -52.8% -38.1%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?